Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 16.09.2022

Fiskars Corporation   Stock Exchange Release 16.09.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 16.09.2022   Date 16.09.2022  Exchange transaction Buy  Share class FSKRS  Amount  9,300  Average price/share 15.8140 EURHighest price/share 15.9200 EURLowest price/share 15.5600 EURTotal price 147,070.20 EUR        The shares held by Fiskars Corporation on 16.09.2022   FSKRS 1,110,153       On

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 16.09.2022

United Bankers Plc NOTIFICATION   16.09.2022 at 18:30   UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 16.09.2022   Date 16.09.2022  Exchange transaction Buy  Share class UNITED  Amount 96  Average price/share 13.6000 EURHighest price/share 13.6000 EURLowest price/share 13.6000 EURTotal price 1,305.60 EUR        The shares held by United Bankers Plc on 16.09.2022:   UNITED 60,538         On behalf of United

OKEA ASA - Mandatory notification of trade

(Trondheim, 16 September 2022) OKEA ASA (OSE: OKEA): BCPR Pte. Ltd (a closely related party to Mike Fischer, board member in OKEA and Chaiwat Kovavisarach, chairman of the board of directors in OKEA), has today sold a total of 6,465 shares at an average price of NOK 40.18 pr share. Following the sale, BCPR Pte. Ltd holds 47,218,098 shares in OKEA. Copy of notification is attached hereto. This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 and section 5-12 of the Norwegian Securities Trading Act.

CS MEDICA receives order from Alsitan – Alsitan expands their product portfolio

CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that the Company has received an order from Alsitan GmbH (“Alsitan”). The order includes a new advanced arthritis pain gel under a private label for the German territory. The order amounts to 15,000 units and corresponds to an order value of DKK 0,56 million in revenue.Lone Henriksen, CEO CS MEDICA, comments“Alsitan has had a very successful market reception of the arthritis gel in the German market and is now expanding their portfolio with another white label CANNASEN product - a new advanced arthritis pain gel. Together with

#22-324 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#22-323 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

No sales of Pakistani business

the signed sales of Talkpool's shares in Pakistan has not been executedOn the 17[th] of February 2022, Talkpool AG signed Sales Purchase Agreements with Saudi-based ZT Group for the sales on Talkpool’s shareholding in Pakistan and Saudi Arabia and entering a partnership for the Middle East region. The transaction was approved by the Pakistani competition authorities in June 2022, but ZT Group has so far not paid anything to Talkpool AG, thereby breaching the agreed conditions. No shares have been transferred and Talkpool is hence still majority owner of the shares in Pakistan. Talkpool’s

New managing director for Ponsse’s subsidiary in Russia

Ponsse Plc, stock exchange release, 16 September 2022 at 4:30 pm EEST   New managing director for Ponsse’s subsidiary in Russia A new managing director has been appointed for OOO Ponsse, Ponsse’s subsidiary in Russia. Jaakko Laurila, the company’s current managing director, will transfer to another position in Ponsse Group, and Mihail Menshikov will start as the new managing director. In its release issued on 28 June 2022, Ponsse announced that it has signed a deed of sale regarding the sale of all shares in OOO Ponsse to the Russian company OOO Bison. While the process to

Nomination committee for the 2023 Annual General Meeting

In accordance with the resolution by the Annual General Meeting of BillerudKorsnäs, the Chairman of the Board of Directors has convened a Nomination Committee for the Annual General Meeting 2023, appointed by the major shareholders in the company.The Nomination Committee consists of Tomas Risbecker, appointed by AMF Pension & Funds, Michael M.F. Kaufmann, appointed by Frapag Beteiligungsholding AG, Thomas Wuolikainen, appointed by Fourth Swedish National Pension Fund and Lennart Francke, appointed by Swedbank Robur Funds.  Information about the work of the Nomination Committee can be

Chief Operating Officer Torbjörn Gustafsson today also assumes the position as CFO

PowerCell’s Chief Operating Officer Torbjörn Gustafsson today assumes the position as CFO. By combining both roles, Torbjörn Gustafsson gains good insights and control to support PowerCell in its continued growth journey.Torbjörn Gustafsson took over as Chief Operating Officer last spring and has extensive experience in senior positions, most recently as CFO in Christian Berner Tech Trade AB. He has previously, among other things, been CFO for KappAhl and held managerial positions in AB Volvo. “The combined role of CFO and Chief Operating Officer will be instrumental in our continued

Invitation to the webcast of Embracer Group’s Annual General Meeting including selected deep dive information

You are hereby invited to the webcast in connection with the Embracer Group Annual General Meeting on September 21, 2022. At the webcast, the annual operations overview will be supplemented by selected deep dives sections and a presentation of selected parts from Operative Group Gearbox Entertainment by CEO and founder Randy Pitchford. The presentation will also feature Head of Asmodee Research Mikael Le Bourhis, and Asmodee’s Chief Human Resources Officer Cédric Durth. Market insights will then be provided by Tom Wijman, Lead Analyst Games at Newzoo, the world’s leading expert in video games

Additional US installations and new order from Codonics

Pharmacolog's partner, Codonics Inc. recently delivered six WasteLog™ units to new hospitals and placed an additional order for nine WasteLog™ units for immediate delivery.Pharmacolog's exclusive distributor and strategic partner Codonics, Cleveland, Ohio continues to supply WasteLog™ units to leading hospitals in the United States. Codonics has also ordered an additional nine WasteLog™ units from Pharmacolog for immediate delivery. Order value is approximately 2 MSEK. The risk of narcotic drugs ending up in the wrong hands, so-called Drug Diversion, is a serious problem in healthcare.

Members of Stockmann's shareholders’ Nomination Board

STOCKMANN plc, Other information disclosed according to the rules of the Exchange 16.9.2022 at 16:30 EET According to the decision of Stockmann's Annual General Meeting, the Nomination Board consists of representatives of the four shareholders holding largest voting power, as registered in Stockmann's shareholder register as of 1 September 2022 along with the Chair of the Board of Directors as an expert member. The Nomination Board prepares proposals for the Annual General Meeting in 2023 on the composition and remuneration of the Board of Directors. Stockmann's four largest

Agilyx ASA (AGLX) – Agilyx successfully lists on the main list of Oslo Børs

Oslo, [September 16, 2022] – Agilyx ASA (OSE: AGLX; OTCQX: AGXXF) (“Agilyx” or “the company”), a technology company that enables customers to recycle the most challenging post-use plastics to high value, virgin-equivalent products, today has its first day of trading on the main board of Euronext Oslo Børs, following an uplisting from Euronext Growth Oslo. The Agilyx shares trade under the ticker “AGLX” on Oslo Børs and on the US marketplace OTCQX under the ticker “AGXXF”. “The uplisting is an important milestone for Agilyx, almost exactly two years since we first went public on Euronext

LEAX Group AB – LEAX Group invests in Green Tech start-up BRUDELI Green Mobility AS.

Disruptive electrification of commercial long-haul trucking utilizing new leaps in electric transmission technology, BRUDELI offer long-haul trucking powered by 80% electric energy. The BRUDELI Powerhybrid transmission module provides truck owners fuel and range flexibility, and a decisive cost advantage compared to both all electric (BEV) and all diesel (ICE) powered trucks. BRUDELI’s goal is to bring its patented electrified truck transmissions to the market, starting serial deliveries in 2026. The world leading development and industrialization team is located in Hokksund, Norway.

Aiforia Technologies Plc – Managers’ Transactions

Aiforia Technologies Plc COMPANY RELEASE, MANAGERS’ TRANSACTIONS 16 September 2022 04:00 p.m. EEST____________________________________________ Person subject to the notification requirementName: Jukka TapaninenPosition: Chief Executive OfficerIssuer: Aiforia Technologies Oyj LEI: 743700TJRVBX7420Y723Notification type: INITIAL NOTIFICATIONReference number: 19636/5/4____________________________________________ Transaction date: 2022-09-15Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000507934Nature of the transaction: ACQUISITION

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions      16.9.2022 at 15.15Glaston Oyj Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Veli-Matti ReinikkalaPosition: Member of the Board/Deputy member Issuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62Notification type: INITIAL NOTIFICATIONReference number: 19543/7/6____________________________________________ Transaction date: 2022-09-14Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000369657Nature of

Higher risk of serious COVID-19 complications in children with primary immunodeficiency

Children with certain immunodeficiency diseases carry mutations in genes that regulate the body’s immune system against viral infections and they have a higher mortality rate due to COVID-19. This is according to a study by researchers from Karolinska Institutet in Sweden, published in the Journal of Allergy and Clinical Immunology.Most children infected with the SARS-CoV-2 coronavirus develop a mild illness or show no symptoms at all. But for a small percentage, serious complications may develop. “Mortality is much higher among children with primary immunodeficiency diseases infected

Nixu Corporation’s responsible auditor to change

Nixu Corporation, Stock Exchange Release on 16. September 2022 at 2.45 p.m. EESTNixu Corporation’s responsible auditor to change PricewaterhouseCoopers Oy, the firm of authorised public accountants, has appointed APA Panu Vänskä as the responsible auditor of Nixu Corporation from 1 October 2022. The current auditor APA Enel Sintonen will transfer to another employer. Nixu Corporation Further information:CFO Janne Kärkkäinen, Nixu Corporationtelephone: +358 40 529 4603e-mail: janne.karkkainen@nixu.com Distribution:Nasdaq HelsinkiMain mediawww.nixu.com Nixu in Brief:

Hexagon Purus receives second follow-on order for hydrogen distribution systems and mobile refueling stations from ZE PAK Group

Hexagon Purus, through its wholly owned subsidiary Wystrach GmbH (“Wystrach”), has received a follow-on order for hydrogen distribution systems and mobile refueling stations from ZE PAK Group, Poland’s largest privately owned electricity producer. The follow-on order can be viewed in conjunction with the two separate announcements in Hexagon Purus’ Q4 2021 presentation and on June 16 for hydrogen distribution systems and mobile hydrogen refueling stations. The value of the second follow-on order is approximately EUR 6 million (approximately NOK 60 million). With this recent order, the

Soft launch of Extreme Makeover: Home Edition scheduled for Q4 2022

Qiiwi Games today announce that the soft launch of the company's new major investment within the match-3 genre with the Banijay brand, Extreme Makeover: Home Edition, has a new estimated start date. The goal is now to be able to start the soft launch of the game during the fourth quarter 2022. The reason for the changed start date is that Qiiwi wants to further polish and complete the features and content for the game to be able to compete at the absolute top level of casual match-3 games.Qiiwi has a multi-year license agreement with Banijay Brands, the commercial arm of international

Loncastuximab tesirine receives positive CHMP opinion for the treatment of relapsed or refractory diffuse large B-cell lymphoma

Loncastuximab tesirine receives positive CHMP opinion for the treatment of relapsed or refractory diffuse large B-cell lymphoma   Sobi® and ADC Therapeutics SA today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending the marketing authorisation of loncastuximab tesirine for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), a debilitating orphan disease in haematology. The positive opinion from the CHMP is now referred to the European Commission for a decision.

There are no items matching the current filter
There are no more items matching the current filter
Back to top